Clinical Trial Update: Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma [Phase 1]

View source ↗

Summary

This entry notes a Phase 1 clinical trial evaluating ONO-4685 in patients with relapsed or refractory T-cell lymphoma that is currently recruiting. No results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Drugs mentioned

• ONO-4685

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Relapsed or Refractory T Cell Lymphoma | Phase 1 | Status: RECRUITING